Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

NCT00703339 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of enrollment to the trial. Very difficult population to recruit.

Conditions

Idiopathic Pulmonary Fibrosis
Pulmonary Hypertension

Interventions

DRUG: Treprostinil sodium for inhalation

Sponsor

Lung Biotechnology PBC